Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China
· Delayed Price · Currency is CNY 4.500
-0.010 (-0.22%)
Jun 6, 2025, 2:45 PM CST
SHA:600572 Revenue
In the year 2024, Zhejiang CONBA Pharmaceutical had annual revenue of 6.52B CNY, down -3.23%. Zhejiang CONBA Pharmaceutical had revenue of 1.68B in the quarter ending March 31, 2025, a decrease of -7.64%.
Revenue
6.52B
Revenue Growth
-3.23%
P/S Ratio
1.75
Revenue / Employee
774.60K
Employees
8,411
Market Cap
11.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.52B | -217.63M | -3.23% |
| Dec 31, 2023 | 6.73B | 732.35M | 12.20% |
| Dec 31, 2022 | 6.00B | -567.74M | -8.64% |
| Dec 31, 2021 | 6.57B | 659.17M | 11.16% |
| Dec 31, 2020 | 5.91B | -859.28M | -12.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |